These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36046748)

  • 1. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology.
    Yin X; Li J; Hao Z; Ding R; Qiao Y
    Front Cell Infect Microbiol; 2022; 12():964469. PubMed ID: 36046748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
    Li S; Hao L; Hu X; Li L
    Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of emodin in treating hepatitis B virus-associated hepatocellular carcinoma: network pharmacology and cell experiments.
    Wang Y; Li S; Ren T; Zhang Y; Li B; Geng X
    Front Cell Infect Microbiol; 2024; 14():1458913. PubMed ID: 39346898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the effect of Gupi Xiaoji Prescription on hepatitis B virus-related liver cancer through network pharmacology and in vitro experiments.
    Yu S; Gao W; Zeng P; Chen C; Zhang Z; Liu Z; Liu J
    Biomed Pharmacother; 2021 Jul; 139():111612. PubMed ID: 33915505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Euphorbia helioscopia L. extract suppresses hepatitis B virus-related hepatocellular carcinoma via alpha serine/threonine-protein kinase and Caspase-3.
    Xiong D; Gong M; Hou Y; Chen H; Gao T; He L
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):442. PubMed ID: 39356361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
    Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
    Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
    Yan SY; Fan JG; Qio L
    Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy.
    Jang JW
    World J Gastroenterol; 2014 Jun; 20(24):7675-85. PubMed ID: 24976705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3.
    Tan X; Ma X; Dai Y; An J; Yu X; Li S; Liao Y; Pei T; Tang Y; Gui Y; Zhou S; Guo D; Deng Y; Hu K; Wang D
    Phytomedicine; 2023 Nov; 120():155031. PubMed ID: 37666060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the mechanisms underlying the therapeutic effect of the
    Qing L; Pan B; He Y; Liu Y; Zhao M; Niu B; Gao X
    Aging (Albany NY); 2022 Nov; 14(22):9103-9127. PubMed ID: 36403263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
    Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
    J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
    Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
    World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
    Yu SJ; Kim YJ
    World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the Traditional Chinese Medicine (TCM) Syndrome with the Best Prognosis of HBV-Related HCC and Exploring the Related Mechanism Using Network Pharmacology.
    Wu Z; Wei C; Wang L; He L
    Evid Based Complement Alternat Med; 2021; 2021():9991533. PubMed ID: 34306165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
    Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.